Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03872700 · ClinicalTrials.gov registry record · Phase 3
Intranasal Fentanyl as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage
A Phase 3 study of Abscess, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 49
- Enrollment target
- 1
- Study location
NCT03872700: Completed Phase 3 study of Abscess, sponsored by Montefiore Medical Center.
NCT03872700 is a Phase 3 study of Abscess that has completed, run by Montefiore Medical Center. The registered enrollment target is 49 participants, below the 386-participant average among 13 other Abscess trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03872700, a Phase 3 study of Abscess, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized clinical trial aims to compare the analgesic efficacy of intranasal fentanyl to placebo as analgesic adjunct to conventional local anesthesia for the treatment of pain of the overall procedure in adult patients undergoing lidocaine infiltration and subsequent abscess incision and drainage in the Emergency Department (ED).
Primary Outcome
Patient reported pain scores at baseline. The NRS for pain is a reliable and validated measure of pain intensity ranging from 0 - no pain, to 10 - worst pain imaginable.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Intranasal fentanyl
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2022-12-31 |
| Phase | Phase 3 |
What the finished NCT03872700 record still lists
NCT03872700 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 386-participant average among 13 other Abscess trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Abscess appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03872700 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03872700 about?
NCT03872700 is a clinical study titled "Intranasal Fentanyl as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage". This randomized clinical trial aims to compare the analgesic efficacy of intranasal fentanyl to placebo as analgesic adjunct to conventional local anesthesia for the treatment of pain of the overall procedure in adult patients undergoing lidocaine infiltration and subsequent abscess incision and dra...
What is the current status of trial NCT03872700?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 49 participants. The study started on 2019-08-01. Estimated completion is 2022-12-31.
What conditions does trial NCT03872700 study?
This clinical trial studies the following conditions: Abscess.
What interventions are being tested in trial NCT03872700?
The interventions under investigation include: Placebo (DRUG), Intranasal fentanyl (DRUG).
Who is sponsoring clinical trial NCT03872700?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03872700 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abscess
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03872700's enrollment target sits among peer trials
49 10th of 13 higher than 4 of 13 other Abscess trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Abscess trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Intranasal Fentanyl at Reducing Pain During Abscess Incision and Drainage (I&D) in Children
COMPLETED · Phase 3
-
Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage
COMPLETED · Phase 3
-
Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
COMPLETED · Phase 3
-
Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
COMPLETED · Phase 3
-
Incision and Drainage Versus Needle Aspiration in Soft Tissue Abscesses
COMPLETED · Phase 3
-
Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI